EphB receptor activity suppresses colorectal cancer progression.
about
Loss of Nkx3.1 leads to the activation of discrete downstream target genes during prostate tumorigenesisEph/ephrin molecules--a hub for signaling and endocytosisMouse models of intestinal cancerEphA receptor signaling--complexity and emerging themesNormal morphogenesis of epithelial tissues and progression of epithelial tumors.EphrinB1 expression is dysregulated and promotes oncogenic signaling in medulloblastoma.Three-dimensional Structure of the EphB2 Receptor in Complex with an Antagonistic Peptide Reveals a Novel Mode of InhibitionGene expression profiling identifies EPHB4 as a potential predictive biomarker in colorectal cancer patients treated with bevacizumab.Signal transducer and activator of transcription 3 (STAT3) protein suppresses adenoma-to-carcinoma transition in Apcmin/+ mice via regulation of Snail-1 (SNAI) protein stabilityThe SAM domains of Anks family proteins are critically involved in modulating the degradation of EphA receptorsPEGylation potentiates the effectiveness of an antagonistic peptide that targets the EphB4 receptor with nanomolar affinityEphB2 receptor controls proliferation/migration dichotomy of glioblastoma by interacting with focal adhesion kinaseGermline variants and advanced colorectal adenomas: adenoma prevention with celecoxib trial genome-wide association study.EPHB2 germline variants in patients with colorectal cancer or hyperplastic polyposis.The pro-apoptotic K-Ras 4A proto-oncoprotein does not affect tumorigenesis in the ApcMin/+ mouse small intestine.Germline EPHB2 receptor variants in familial colorectal cancer.IRS1 regulation by Wnt/beta-catenin signaling and varied contribution of IRS1 to the neoplastic phenotype.Overexpression of erythropoietin-producing hepatocyte receptor B4 and ephrin-B2 is associated with estrogen receptor expression in endometrial adenocarcinoma.Murine models of colorectal cancer.PDGFRβ reverses EphB4 signaling in alveolar rhabdomyosarcoma.The small molecule specific EphB4 kinase inhibitor NVP-BHG712 inhibits VEGF driven angiogenesisChromosome 13q deletion syndrome involving 13q31‑qter: A case report.Aberrant DNA methylation and epigenetic inactivation of Eph receptor tyrosine kinases and ephrin ligands in acute lymphoblastic leukemia.High expression of erythropoietin-producing hepatoma cell line-B2 (EphB2) predicts the efficiency of the Qingyihuaji formula treatment in pancreatic cancer CFPAC-1 cells through the EphrinB1-EphB2 pathway.Eph receptors and ephrins in cancer: bidirectional signalling and beyond.TGF-β mediated DNA methylation in prostate cancer.EphrinB1 interacts with CNK1 and promotes cell migration through c-Jun N-terminal kinase (JNK) activationThe differential expression of EphB2 and EphB4 receptor kinases in normal bladder and in transitional cell carcinoma of the bladderTranscriptional silencing of the Wnt-antagonist DKK1 by promoter methylation is associated with enhanced Wnt signaling in advanced multiple myelomaRecent progress in histochemistry and cell biology.Eph receptor tyrosine kinases in cancer stem cellsColorectal serrated adenocarcinoma.Replication of a genome-wide case-control study of esophageal squamous cell carcinoma.Acute overexpression of Myc in intestinal epithelium recapitulates some but not all the changes elicited by Wnt/beta-catenin pathway activationEph/ephrin signaling in epithelial development and homeostasisIdentification of the angiogenic gene signature induced by EGF and hypoxia in colorectal cancer.Loss of Apc allows phenotypic manifestation of the transforming properties of an endogenous K-ras oncogene in vivoEph receptors and ephrins as targets for cancer therapy.Natural positive selection and north-south genetic diversity in East Asia.Eph receptor function is modulated by heterooligomerization of A and B type Eph receptors
P2860
Q24314483-41A8481E-FD97-467F-B5B9-7CE09F9DA448Q24611588-3ED8BF69-649C-47A2-A028-FCEC53EE7336Q26785563-7FBC8912-7E97-4881-8AE1-825ED0C68E26Q26864082-1F53F770-89AB-4551-AC8C-F97901046607Q27015094-19CB47A3-38E9-43EB-8228-ACF72930E7F7Q27314970-D6AC6BCD-34F7-47ED-AE21-01A4CDF09FF0Q27648574-692ADD34-EFEF-447A-95C6-8FF59C181CDAQ27852191-76003A1A-1750-4F3A-89D9-52336534E172Q28264306-81677FAD-BD8F-4F92-98F1-07D16BD772A8Q28507101-759478E4-9A81-433F-BEF4-2941C964700BQ28741459-72FB3C30-9AC0-44DE-9337-0CBD5A730423Q30514025-A27641F0-92DA-4582-B95B-A80DFE7546DAQ30579114-8714A121-7F9C-4669-9EE7-54076E7F65CDQ33245402-7E9838A6-AA65-4EB7-9F1D-C3FBC0E19549Q33343709-8E733B45-5EAA-4797-9FA2-AB068CF997CAQ33358071-1A470F5D-9DEF-4559-859B-D5161588C73AQ33581982-C24EE1DD-EB37-45BC-8814-B933E65C7FFAQ33599430-868A4AE6-B1AD-438C-B43F-62EC009CE92BQ33640905-D9A966DF-E93A-4359-B12E-12B64F2A250FQ33674238-15293579-1887-48E8-A9FB-1DB724AEEEE6Q33677805-94DED417-2DFD-4185-BEC1-30AB4E6D8659Q33702488-0CAA3946-103A-4DB5-8639-F3D3CC0F9B99Q33754623-D470F998-E5FF-41A9-AE95-5C76077ED9D3Q33778296-B076A456-438D-476E-899A-7738A1C4812CQ34021365-6AA2FC9E-FCFE-4112-AB03-1A81551FF142Q34039935-967E9FD5-BE76-4164-9A43-15FC274609EFQ34073875-3AB88814-5645-4F22-8C3D-2F2296B9381FQ34078717-3F98EABE-A651-4518-BBAC-22390AA017F1Q34169968-54A88A18-DE29-46BD-8C16-C182AD50F244Q34172616-5BA10606-022B-4660-97B9-49EB97F9623BQ34527304-96C1955A-3649-4CE9-824F-93E65F3B640EQ34597935-089DADFD-67D6-419F-B080-D0315D98F831Q34799701-59FD5122-2EC4-49F5-848B-4F164429AC52Q34994378-18C459AB-52F7-4A2E-884A-40951EBC0B61Q35026768-60690C56-F8FF-48B7-B013-F77B5F29C378Q35030421-11DF44D8-C692-4688-ABEB-E56A4F8C2CCFQ35080479-0784AB98-084B-4F23-94C2-C9FA7496CAECQ35370195-F6507964-793C-4F93-8305-4F3F418062A0Q35603642-11B4544E-26C6-4F3C-B488-69F5A7731DFCQ35621005-606B3A25-8D91-4E16-B60D-07C1F2BDDB17
P2860
EphB receptor activity suppresses colorectal cancer progression.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
EphB receptor activity suppresses colorectal cancer progression.
@en
type
label
EphB receptor activity suppresses colorectal cancer progression.
@en
prefLabel
EphB receptor activity suppresses colorectal cancer progression.
@en
P2093
P2860
P50
P356
P1433
P1476
EphB receptor activity suppresses colorectal cancer progression.
@en
P2093
Alexander Gregorieff
Elles Boon
Hans Clevers
Harry Begthel
Julinor Bacani
Maaike van de Born
Núria Malats
Steven Pals
Suzanne Jonkheer
Tony Pawson
P2860
P2888
P304
P356
10.1038/NATURE03626
P407
P577
2005-06-01T00:00:00Z
P6179
1050795978